Canada markets closed

Asarina Pharma AB (publ) (APS.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0632+0.0006 (+0.96%)
At close: 09:15AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
8,421
7,294
29,922
63,749
Selling General and Administrative
3,471
3,088
3,985
7,444
Total Operating Expenses
16,205
14,687
38,284
81,406
Operating Income or Loss
-16,205
-14,687
-38,284
-81,406
Interest Expense
-25
298
395
201
Income Before Tax
-16,119
-14,828
-38,297
-82,994
Income Tax Expense
-1,545
-1,545
-6,639
-7,738
Income from Continuing Operations
-14,574
-13,283
-31,658
-75,256
Net Income
-14,574
-13,283
-31,658
-75,256
Net Income available to common shareholders
-14,574
-13,283
-31,658
-75,256
Basic EPS
-0.69
-0.71
-1.69
-4.02
Diluted EPS
-0.69
-0.71
-1.69
-4.02
Basic Average Shares
20,714
18,788
18,745
18,703
Diluted Average Shares
21,449
19,605
20,038
19,573